Литература
- Wang K. K., Sampliner R. E. Diagnosis, Surveillance and Therapy of
Barrett’s Esophagus //Am J Gastroenterol. – 2008. – Т. 103. – С. 788-797.
- Spechler S. J. et al. American Gastroenterological Association medical
position statement on the management of Barrett's esophagus
//Gastroenterology. – 2011. – Т. 140. – №. 3. – С. 1084.
- Ивашкин В.Т., Маев И.В., Трухманов А.С. Пищевод Баррета. В двух томах. М.:
Издательство "Шико", 2011.
- Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, Dunne
D,Rahmani EY, Helper DJ. Screening for Barrett's esophagus in colonoscopy
patients with and without heartburn. Gastroenterology. 2003 Dec;125(6):1670-7.
PubMed
- Van Blankenstein M, Looman CW, Johnston BJ, Caygill CP. Age and sex
distribution of the prevalence of Barrett's esophagus found in a primary
referral endoscopy center. Am J Gastroenterol. 2005 Mar;100(3):568-76.
- Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of
columnar-lined (Barrett's) esophagus. Comparison of population-based clinical
and autopsy findings. Gastroenterology. 1990 Oct;99(4):918-22.
- Hirota W. , Loughney T. and Lazas D. et al. (1999) Specialized intestinal
metaplasia, dysplasia and cancer of the esophagus and esophagogastric
junction: Prevalence and clinical data. Gastroenterology 116:277-285
- Blot W.J., Devesa S.S. and Kneller R.W. et al. (1991) Rising incidence
of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287-1289
- Devesa S.S. , Blot W.J. and Fraumeni J. (1998) Changing patterns in the
incidence of esophageal and gastric carcinoma in the United States. Cancer
83:2049-2053
- Годжелло Э.А., Галлингер Ю.И. Пищевод Баррета и аденокарционома пищевода:
эндоскопическая диагностика и лечение // Рос. онкол. журн. – 2000. – No 6. –
С. 50–52.
- Cook M.B., Wild C.P., Forman D. A systematic review and meta-analysis of
the sex ratio for Barrett’s esophagus, erosive reflux disease, and nonerosive
reflux disease // Am. J. Epidemiol. – 2005. – Vol. 11. – Р. 1050–1061.
- Осипенко М. Ф. и др. Пищевод Барретта – современное состояние проблемы
//Российский журнал гастроэнтерол., гепатол., колоп роктол. – 2007. – №. 4. –
С. 11.
- Irani S., Parkman H.P., Thomas R. Increased Barrett’s esophagus for the
decade between 1991 and 2000 at a single university medical center // Dig.
Dis. Sci. – 2005. – N 11. – Р. 2141–2146.
- Shaheen NJ, Crosby MA, Bozymski EM, et al. Is there publication bias in
the reporting of cancer risk in Barrett’s esophagus? Gastroenterology
2000;119:333–338.
- Desai TK, Singh J, Samala N, Subbiah P. The incidence of esophageal
adenocarcinoma in Barrett's esophagus has been overestimated. Am J
Gastroenterol.2011 Jul;106(7):1364-5
- Amin A., Samala N. R., Desai T. K. The Incidence of Esophageal
Adenocarcinoma in Barrett's Esophagus (BE) Low Grade Dysplasia (LGD) is 1 to
1.9% Annually and May Be a Fraction of Non-Esophageal Mortality: A
Meta-Analysis of 40 Studies //Gastroenterology. – 2011. – Т. 140. – №. 5. – С.
S-223.
- Reid B. , Levine D. and Longton G. et al. (2000) Predictors of progression
to cancer in Barrett's esophagus: Baseline histology and flow cytometry
identify low and high risk patient subsets. Am J Gastroenterol 95:1669-1676
- Gatenby PA, Caygill CP, Watson A, Murray L, Romero Y. Barrett's esophagus
registries. Ann N Y Acad Sci. 2011 Sep;1232:405-10.
- Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie
MK, van Baal JW, Siersema PD. Surveillance and follow-up strategies in
patients with high-grade dysplasia in Barrett's esophagus: a Dutch
population-based study. Am J Gastroenterol. 2012 Apr;107(4):534-42
- Ивашкин В.Т., Трухманов А.С. Болезни пищевода. – М.: Триада-Х, 2000. – 179
с.
- Ивашкин В.Т., Шептулин А.А. Болезни пищевода и желудка. – М.:
МЕДпресс-информ, 2002. – 143 с.
- Sharma P., McQuaid K. et al. AGA Chicago Workshop. A critical review of
the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop
//Gastroenterology. – 2004. – Vol. 127. – P. 310–330.
- Spechler S.J., Goyal R.K. The columnar lined esophagus, intestinal
metaplasia, and Norman Barrett //Gastroenterology.– 1996. – Vol. 110. – P.
614–621.
- Кардашева С. С. и др. Клиническая картина, факторы риска и
иммуногистохимические маркеры при пищеводе Барретта //Рос.журн.
гастроэнтерол., гепатол., колопроктол N. – 2008. – Т. 3. – С. 15-24.
- Spechler S.J. Barrett’s esophagus // N. Engl. J. Med. – 2002. – Vol. 346.
– P. 836–842.
- Пирогов С. С. и др. Новый взгляд на проблему пищевода Баррета. – 2008.
- Choi do W., Oh S.N., Baek S.J. et al. Endoscopically observed lower
esophageal capillary patterns // Korean J. Intern. Med. – 2002. – Vol. 17, N
4. – P. 245–248.
- Egger K., Meining A., Werner M. et al. Endoscopic measurement of Barrett’s
esophagus length is unreliable – a prospective comparative biopsy study // Z.
Gastroenterol. – 2004. – Vol. 42, N 6. – P. 499–504.
- Van Eyken P. Definition of Barrett’s esophagus // Acta Gastroenterol.
Belg. – 2000. – Vol. 63, N 1. – P. 10–12
- Pohl H, Welch HG. The role of overdiagnosis and reclassification in the
marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst
2005;97:142–146.
- Sikkema M, De Jonge PJF, Steyerberg EW, et al. Risk of esophageal
adenocarcinoma and mortality in patient with Barrett’s esophagus: a systematic
review and meta-analysis. Clin Gastroenterol Hepatol 2010;8:235–244.
- Thomas T, Abrams KR, DeCaestecker JS, et al. Meta analysis: cancer risk in
Barrett’s oesophagus. Aliment Pharmacol Ther 2007;26:1465–1477.
- Yousef F, Cardwell C, Cantwell MM, et al. The incidence of esophageal
cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review
and meta-analysis. Am J Epidemiol 2008;168:237–249
- Wani S, Falk G, Hall M, et al. Patients with nondysplastic Barrett’s
esophagus have low risks for developing dysplasia or esophageal
adenocarcinoma. Clin Gastroenterol Hepatol 2011;9:220–227.
- Boeing H, Dietrich T, Hoffmann K. et al. Intake of fruits and vegetables
and risk of cancer of the upper aero-digestive tract: the prospective
EPIC-study.Cancer Causes Control. 2006 Sep ;17(7):957-69.
- Dong LM, Kristal AR, Peters U. et al.Dietary supplement use and risk of
neoplastic progression in esophageal adenocarcinoma: a prospective study.Nutr
Cancer. 2008;60(1):39-48.
- Yates M. et al. Dietary fat intake in the aetiology of Barrett's
oesophagus and oesophageal adenocarcinoma–data from a prospective cohort study
(EPIC-Norfolk) using 7-day food diary data //Gastroenterology. – 2011. – Т.
140. – №. 5. – С. S-80.
- Leggett C. L. et al. Metabolic Syndrome as a Risk Factor for Barrett
Esophagus: A Population-Based Case-Control Study //Mayo Clinic Proceedings. –
Elsevier, 2013. – Т. 88. – №. 2. – С. 157-165.
- Nelsen E. M. et al. Distribution of body fat and its influence on
esophageal inflammation and dysplasia in patients with Barrett's esophagus
//Clinical Gastroenterology and Hepatology. – 2012. – Т. 10. – №. 7. – С.
728-734.
- Ogunwobi O. Leptin enchances the cell proliferative and anti-apoptotic
actions of acid in Barrett’s adenocarcinoma 13 UEGW. – p. 6.
- Kara M.A., Peters F.P., Rosmolen W.D. et al. High- resolution endoscopy
plus chromoendoscopy or narrow-band imaging in Barrett’s esophagus: a
prospective randomized crossover study // Endoscopy. – 2005. – Vol. 37, N 10.
– Р. 929–936.
- Kuipers E.J., Haringsma J. Diagnostic and therapeutic endoscopy // J.
Surg. Oncol. – 2005. – Vol. 92, N 3. – Р. 203–209.
- Guda N.M., Partington S., Vakil N. Inter- and intra- observer variability
in the measurement of length at endoscopy: Implications for the measurement of
Barrett’s esophagus // Gastrointest. Endosc. – 2004. – Vol. 59, N 6. – Р.
655–658.
- Spechler S.J. Screening and surveillance of Barrett’s esophagus //
Gastroenterol. Hepatol. – 2005. – Vol. 1,N 2. – P. 91–93.
- Armstrong D., Marshall J.K., Chiba N. Canadian Association of
Gastroenterology GERD Consensus Group. Canadian Consensus Conference on the
management of gastroesophageal reflux disease in adults – update 2004 // Can.
J. Gastroenterol. – 2005. – Vol. 19, N 1. – Р. 15–35.
- El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner
RE.Proton pump inhibitors are associated with reduced incidence of dysplasia
inBarrett's esophagus. Am J Gastroenterol. 2004 Oct;99(10):1877-83.
- Mardini HE. Preventing dysplasia in Barrett's esophagus: are proton pump
inhibitors the answer? Am J Gastroenterol. 2005 Apr;100(4):978-9.
- Abdalla S.I., Lao-Sirieix P., Novelli M.R. et al.Gastrin-induced
cyclooxygenase-2 expression in Barrett’s carcinogenesis // Clin. Cancer Res. –
2004. – Vol. 10. – Р. 4784– 4792.
- Corey K.E., Schmitz S.M., Shaheen N.J. Does a surgical antireflux
procedure decrease the incidence of esophageal adenocarcinoma in Barrett’s
esophagus? A meta-analysis // Am. J. Gastroenterol. – 2003. – Vol. 98, N 11. –
Р. 2390–2394.
- Spechler S.J., Lee E., Ahnen D. Long-term outcome ofmedical and surgical
therapies for gastroesophageal reflux disease: follow-up of a randomized
controlled trial // JAMA. – 2001. – Vol. 285, N 18. – Р. 2331–2338.
- Gross G. , Canto M. and Hixson J. et al. (1999) Management of Barrett's
esophagus. A national study of practice patterns and their cost implications.
Am J Gastroenterol 94:3440-3447
- Falk G. , Ours T. and Richter J. (2000) Practice patterns for surveillance
of Barrett's esophagus in the United States. Gastrointest Endosc 52:197-203
- Sharma P. , Sampliner R.E. and Camargo E. (1997) Normalization of
esophageal pH with high dose proton pump inhibitor therapy does not result in
regression of Barrett's esophagus. Am J Gastroenterol 92:582-585
- Malesci A. , Savarino V. and Zenith P. et al. (1996) Partial regression of
Barrett's esophagus by long term therapy with high dose omeprazole.
Gastrointest Endosc 44:700-705
- Peters F. , Ganesh S. and Kuipers E. et al. (1999) Endoscopic regression
of Barrett's oesophagus during omeprazole treatment: A randomised double blind
study. Gut 45:489-494
- Salo J.A. , Nemlander A. and Farkkila M. et al. (1996) Treatment of
Barrett's metaplasia by antireflux surgery and endoscopic laser ablation.
Clinical experience in ten patients. Gastroenterology 108:A1243(abstract)
- Sampliner R.E., Fennerty M.B. and Garewal H.S. (1996) Reversal of
Barrett's esophagus with acid suppression and multipolar electrocoagulation:
Preliminary results. Gastrointest Endosc 44:523-525
- Overholt B.F. and Panjehpour M. (1996) Photodynamic therapy for Barrett's
esophagus: Clinical update. Am J Gastroenterol 91:1719-1723
- Schulz H. , Meihlke S. and Antos D. et al. (2000) Ablation of Barrett's
epithelium by endoscopic argon plasma coagulation in combination with high
dose omeprazole. Gastrointest Endosc 51:659-663
- РГА. Диагностика и лечение гастроэзофагеальной рефлюксной болезни //
Пособие для врачей. - Москва. - 2010 г.
-
Трухманов А.С. Гастроэзофагеальная рефлюксная болезнь: клинические варианты,
прогноз, лечение: Автореф. д-ра мед.наук. - М., 2008. - 41 с.
-
Кайбышева В.О., Трухманов А.С., Ивашкин В.Т. Гастроэзофагеальная рефлюксная
болезнь, резистентная к терапии ингибиторами протонной помпы // РЖГГК. – 2011.
– Т. ХХI. – № 4. – С. 4–13.
- Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in
primary care: an international study of different treatment strategies with
omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol
1998;10:119–24.
- Crawley JA, Schmitt CM. How satisfied are chronic heartburn sufferers with
their prescription medications? Results of the Patient Unmet Needs Study. J
Clin Outcomes Manag 2000;7:29–34.
- Inadomi JM, McIntyre L, Bernard L, et al. Step-down from multiple- to
single-dose proton pump inhibitors (PPIs): a prospective study of patients
with heartburn or acid regurgitation completely relieved with PPIs. Am J
Gastroenterol 2003;98:1940–4.
-
Буеверов О.А., Лапина Т.Л. Дуоденогастроэзофагеальный рефлюкс как причина
рефлюкс–эзофагита // Фарматека – 2006. – №1. – С.22–27.
- Pazzi P, et al. Bile reflux gastritis in patients without prior gastric
surgery: therapeutic effects of ursodeoxycholic acid. Curr Ther Res 1989;45:
476-87.
-
Кайбышева В.О., Сторонова О.А., Трухманов А.С., Ивашкин В.Т. Возможности
внутрипищеводной рН-импедансометрии в диагностике ГЭРБ //РЖГГК. – 2013. –
Т.23. – № 2. – С. 4-16.
- Kahrilas P, Shaheen N, Vaezi M. American Gastroenterological Association
Institute Technical Review on the Management of Gastroesophageal Reflux
Disease.Gastroenterology 2008;135:1392–1413.
- Пирогов С.С. Эндоскопические методики в уточняющей диагностике и лечении
больных с пищеводом Барретта : автореф. дис. канд. мед.наук : 14.00.14. - M,
2010.
- Sharma P, Dent J, Armstrong D et al. The development and validation of an
endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.
Gastroenterology 2006; 131: 1392-9.
- Pascu O, Lencu M. Barrett's esophagus. Rom. J. Gastroenterol. 2004; 13:
219-22.
- Lukanich Jeanne M. Section I: epidemiological review. Semin Thorac
Cardiovasc Surg. 2003 Apr;15(2):158–166.
- Solaymani-Dodaran M. et al. Risk of oesophageal cancer in Barrett’s
oesophagus and gastro-oesophageal reflux //Gut. – 2004. – Т. 53. – №. 8. – С.
1070-1074.
- Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald
E, Vieth M, Stolte M, Talley NJ, Agréus L. Prevalence of Barrett's esophagus
in the general population: an endoscopic study. Gastroenterology. 2005
Dec;129(6):1825-31.
- Conio M. et al. Risk factors for Barrett's esophagus: A case-control study
//International journal of cancer. – 2002. – Т. 97. – №. 2. – С. 225-229.
- Breyer HP, Silva De Barros SG, Maguilinik I, et al. Does methylene blue
detect intestinal metaplasia in Barrett’s esophagus? Gastrointest Endosc
2003;57:505-9.
- Руководство по гастроэнтерологии под ред. Комарова Ф. И., Гребенева А.Л.,
Шептулина А.А.– М.: Медицина – 1995 - Т.1-3.
- Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, et al. Molecular
evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the
esophagus.//Am J Pathology – 1999 – V.154 - №4 – P.965-973.
- Beigi FI, Horton PF, Pope CE. Histological consequences of
gastroesophageal reflux in man.//Gastroenterology – 1970 – V.58 – N.2 –
P.163-174.
- Clickman JN, Chen JJ, Wang HH, et al. Phenotypic characteristics of a
distinctive multilayered epithelium suggests that it is a precursor in the
development of Barrett′s esophagus.//Am J Surg Pathol – 2001 – V.25 – P.
569-578.
- Barrett's Esophagus. / Giuli R., Siewert J., Couturier D., et al. – Paris:
John Libbey Eurotext – 2003 – V.1-2.
- Overholt B., Lightdale C., Wang K., et al. International, multicenter,
partally blinded, randomized study of the efficacy of photodynamic therapy
(PDT) using porfimer sodium for the ablation of high grade dysplasia in
Barrett’s esophagus: result of 24-month follow-up.// Gastroenterology – 2003-
V.124 .
- Sampliner R. Endoscopic ablative therapy for Barrett’s esophagus.//
Gastrointest Endosc. – 2004 – V.59 – P. 66-69.
- Каприн А.Д., Старинский В.В., Г.В. Петрова. Состояние онкологической
помощи населению России в 2012 году -М.: ФГУ «МНИОИ им. П.А. Герцена
Минздравсоцразвития России», 2014.- 260 с
- Шептулин А.А. Современные возможности и перспективы лечения резистентных
форм гастроэзофагеальной рефлюксной болезни. РЖГГК. - 2010. - Т.20. - №6.
-С.81-85.
- Fass R, Sifrim D. Management of heartburn not responding to proton pump
inhibitors. Gut 2009;58:295–309.
- Mueller J, Werner M, Stolte M. Barrett’s esophagus: histopathologic
definitions and diagnostic criteria. World J Surg 2004;28:148-54.
- Goldblum JR. The significance and etiology of intestinal metaplasia of the
esophagogastric junction. Ann Diagn Pathol 2002;6:67-73.
- Spechler SJ. Short and ultrashort Barrett’s esophagus -- what does it
mean. Semin Gastrointest Dis 1997;8:59-67.
- Weston AP, Krmpotich PT, Cherian R, et al. Prospective long-term
endoscopic and histological follow-up of short segment Barrett’s esophagus:
comparison with traditional long segment Barrett’s esophagus. Am J
Gastroenterol 1997;92:407-13.
- Chang Y, Liu B, Liu GS, et al. Short-segment Barrett’s esophagus and
cardia intestinal metaplasia: A comparative analysis. World J Gastroenterol
2010;16:6151-4.
- Goldblum JR, Richter JE, Vaezi M, et al. Helicobacter pylori infection,
not gastroesophageal reflux, is the major cause of inflammation and intestinal
metaplasia of gastric cardiac mucosa. Am J Gastroenterol 2002;97:302-11.
- Wijetunge S, Ma Y, DeMeester S, et al. Association of adenocarcinoma of
the distal esophagus, “gastroesophageal junction,” and “gastric cardia” with
gastric pathology. Am J Surg Pathol 2010;34:1521-7.
- Chandrasoma P, Wickramasinghe K, Ma Y, et al. Is intestinal metaplasia a
necessary precursor lesion for adenocarcinomas of the distal esophagus,
gastroesophageal junction and gastric cardia? Dis Esophagus 2007;20:36-41.
- Chandrasoma P, Wijetunge S, DeMeester S, et al. Columnar-lined esophagus
without intestinal metaplasia has no proven risk of adenocarcinoma. Am J Surg
Pathol 2012;36:1-7.
- Cassie L. Booth, Kevin S. Thompson. Barrett’s esophagus: A review of
diagnostic criteria, clinical surveillance practices and new developments.J
Gastrointest Oncol. 2012 September; 3(3): 232–242.
- Theisen J, Nigro JJ, DeMeester TR, et al. Chronology of the Barrett’s
metaplasia-dysplasia-carcinoma sequence. Dis Esophagus 2004;17:67-70.
- Cameron AJ, Carpenter HA. Barrett’s esophagus, high- grade dysplasia, and
early adenocarcinoma: a pathological study. Am J Gastroenterol 1997;92:586-91.
- Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis
of dysplasia in Barrett’s esophagus. Hum Pathol 1988;19:166-78.
- Zhu W, Appelman HD, Greenson JK, et al. A histologically defined subset of
high-grade dysplasia in Barrett mucosa is predictive of associated carcinoma.
Am J Clin Pathol 2009;132:94-100.
- Зайратьянц О.В., Зайратьянц Г.О., Мовтаева П.Р. Проблемы современной
гастроэнтерологии: пищевод Барретта. // Клиническая и экспериментальная
морфология. - 2011. - №2. – С.9-11.
- Зайратьянц О.В. Маев И.В. Смольянникова В.А., Мовтаева П.Р. Патологическая
анатомия пищевода Барретта. // Архив патологии. – 2011. - №3. – С.21-22
- Чистяков С.С, Пирогов С.С., Кувшинов Ю.П. Опухоли пищеварительного тракта:
Учебное пособие // Издательство: МИА Классификация: Онкология ISBN:
5894818575, 2011
- Superficial and early cancers of the esophagus.//Davydov М, Delektorskaya
VV, Kuvshinov YP, Lisovsky M, Pirogov SS, Udagawa H, Ueno M, Wang G. Ann N Y
Acad Sci. 2014 Sep;1325:159-69. doi: 10.1111/nyas.12527.
- Пирогов С.С., Соколов В.В., Каприн А.Д. и др. Конфокальная лазерная
эндомикроскопия.принцип и алгоритм выполнения при исследовании желудка //
Экспериментальная и клиническая гастроэнтерология, №3, 2014 с. 10-16
- Rüdiger Siewert J, Feith M, Werner M, Stein HJ. Adenocarcinoma of the
esophagogastric junction: results of surgical therapy based on
anatomical/topographic classification in 1,002 consecutive patients. Ann Surg.
2000 Sep;232(3):353-61.
- Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of
bothmajor histologic types of esophageal carcinomas in selected countries,
1973-1995.Int J Cancer. 2002 Jun 20;99(6):860-8. Erratum in: Int J Cancer 2002
Oct20;101(6):599.
- Stuart A.C. McDonald, Trevor A. Graham, Danielle L. Lavery, Nicholas A.
Wright, Marnix Jansen The Barrett’s Gland in Phenotype Space& Cellular and
Molecular Gastroenterology and Hepatology&
- Stuart J. Spechler Rhonda F. Souza. Barrett's Esophagus. N Engl J Med
2014; 371:836-845
- Fitzgerald RC, di Pietro M, Ragunath K, British Society of
Gastroenterology. British Society of Gastroenterology guidelines on the
diagnosis and management of Barrett's oesophagus. Gut. 2014 Jan;63(1):7-42.
doi: 10.1136/gutjnl-2013-305372.
- Manner H, Neugebauer A, Scharpf M The tissue effect of argon-plasma
coagulation with prior submucosal injection(Hybrid-APC) versus standard APC: A
randomized ex-vivo study. United European Gastroenterol J. 2014
Oct;2(5):383-90
- Hage M, Siersema PD, van Dekken H. 5-aminolevulinic acid photodynamic
therapy versus argon plasma coagulation for ablation of Barrett's oesophagus:
a randomised trial. Gut. 2004 Jun;53(6):785-90
- Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation
of Barrett's esophagus: a systematic review. Am J Gastroenterol.
2011Nov;106(11):1899-90
- Weston AP. Can deep freezing join the endoscopic Barrett's mucosal
ablationparty? Cautious optimism is warranted. Gastrointest Endosc.
2005Dec;62(6):849-52.
- Frank G. Gress,Endoscopic Management of Barrett's Esophagus: Advances in
Endoscopic Techniques. American Society for Gastrointestinal Endoscopy Vol.
16, No. 3 January 2009
- Stein HJ, Feith M, von Rahden BH, Siewert JR. Approach to early Barrett's
cancer. World J Surg. 2003 Sep;27(9):1040-6. Epub 2003 Aug 18.
- Cancer Facts & Figures 2014 cancer.org
- Prasad GA, Wu TT, Wigle DA, Buttar NS. Endoscopic and surgical treatment
of mucosal (T1a)esophageal adenocarcinoma in Barrett's esophagus.
Gastroenterology. 2009 Sep;137(3):815-23
- Tantau M, Mosteanu O, Pop T, Tantau A, Mester G. Endoscopic therapy of
Barrett's esophagus and esophageal adenocarcinoma. J Gastrointestin Liver
Dis.2010 Jun;19(2):213-7. Review.
- American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF,
Inadomi JM, Shaheen NJ. American Gastroenterological Association medical
positionstatement on the management of Barrett's esophagus. Gastroenterology.
2011 Mar;140(3):1084-91.
- Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill
N, British Society of Gastroenterology. British Society ofGastroenterology
guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014
Jan;63(1):7-42
- Gatenby P, Soon Y. Barrett's oesophagus: Evidence from the current
meta-analyses. World J Gastrointes Pathophysiol. 2014 Aug 15;5(3):
1788710.4291 /wjgp. v5.i3.178.
- Bertani H, Frazzoni M, Dabizzi E, Pigò F, Losi L, Manno M, Manta R,
Bassotti G. Improved detection of incident dysplasia by probe-based confocal
laser endomicroscopy in a Barrett's esophagus surveillance program. Dig Dis
Sci. 2013 Jan;58(1):188-93.
|
|